Navigation Links
Crucell in Medical News

PATH Malaria Vaccine Initiative and Crucell to test new malaria vaccine approach

LEIDEN, The Netherlands, July 29, 2009 The US-based PATH Malaria Vaccine Initiative (MVI), the United States Agency for International Development (USAID) Malaria Vaccine Development Program (MVDP), and Dutch biopharmaceutical company Crucell N.V. today announced a collaboration to accelerate deve...

DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6(R) Cell Line Proteins

LEIDEN, Netherlands and PARSIPPANY, N.J., June 25 /PRNewswire/ -- DSM Biologics and Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) announced today that they have entered into an agreement with Avid Bioservices, Inc. of Tustin, California to join their Vendor Network. Under the term...

Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies

Exclusive Agreement for Rabies Monoclonal Antibodies to Fight Fatal Disease LYON, France, January 3 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has signed an exclusive collaboration and commercialization agreement with Crucell ...

Flu virus foiled again

...ersal influenza vaccine. The Scripps research team, led by Ian A. Wilson, Ph.D., in collaboration with researchers at the biopharmaceutical company crucell Holland (The Netherlands), discovered the potent antibody during a systematic examination of blood samples taken from healthy individuals who previous...

Boston Trial to Test New HIV/AIDS Vaccine

...V/AIDS vaccine candidates. The vaccine, the first HIV-1 vaccine candidate to emerge from the IPCAVD program, is made by Dutch biotechnology company crucell Holland B.V. The approach used in developing the rAd26 vaccine enables researchers to circumvent preexisting immunity to serotype 5, the virus resp...

Clinical trial will test new HIV/AIDS vaccine

...sion of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health. Manufactured by the Dutch biotechnology company crucell Holland BV, the rAd26 vaccine is the first HIV-1 vaccine candidate to emerge from the IPCAVD initiative, which brings together investigators from acad...

Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Proposed Dividend

...f alliance agreements with Regeneron, Acambis, crucell and Oxford Biomedica, and buyout of rights to ...ron, Oxford BioMedica (TroVax(R)), UCB (Xyzal(R)), crucell N.V. and Acambis. Acquisitions of investments (e...I (to develop a new tuberculosis vaccine) and with crucell (in monoclonal rabies antibodies), plus an allianc...

Crucell's Rabies MAb Enters Phase I Trial in India

... Dutch biotechnology company, crucell N V’s Rabies monoclonal antibody (mAb) product has entered a phase I clinical study in India, four months after launching// a similar study in the US....
Crucell in Medical Technology

Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa

ATLANTA, April 9, 2008 /PRNewswire-USNewswire/ -- Dutch biotechnology company Crucell N.V., the Aeras Global TB Vaccine Foundation and the South African Tuberculosis Vaccine Initiative (SATVI) present a progress update and immunology data from a Phase I Ad35 tuberculosis vaccine study at th...

ProFibrix Steps up Recombinant Fibrinogen Program With PER.C6(R) License From Crucell

LEIDEN, The Netherlands, January 13 /PRNewswire/ -- ProFibrix B.V., today announced that it has concluded a commercial license agreement with Crucell N.V. (Euronext, NASDAQ: CRXL ; Swiss Exchange: CRX) for PER.C6(R), a unique human protein production platform. The PER.C6(R) platform allows P...

DSM Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms

... In addition to offering world-class biopharmaceutical manufacturing services, DSM Biologics has co-exclusive rights, along with Dutch biotech company crucell N.V., to license the high-producing PER.C6(R) human cell line as a production platform for recombinant proteins and monoclonal antibodies. The combina...

Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine

...l line, licensed from Dutch biotechnology company, crucell N.V. PER.C6 Cell technology offers Sanofi Pasteur ...ion can be found at http://www.lonza.com . About crucell crucell N.V. is a Dutch biotechnology company (Euronext, N...
Crucell in Biological Technology

DSM and Crucell Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6(R) Cell Line Proteins

LEIDEN, The Netherlands, and PARSIPPANY, N.J., Feb. 10 /PRNewswire/ -- DSM Biologics and Crucell N.V. (Euronext, Nasdaq: CRXL ; Swiss Exchange: CRX) announced today that they have entered into an agreement with Bioceros B.V. of Utrecht, The Netherlands to join their Vendor Network. Under the ter...

DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter

PARSIPPANY, N.J. and LEIDEN, Netherlands, Nov. 25 /PRNewswire/ -- DSM Biologics, a business unit of DSM Pharmaceutical Products, and Dutch biotechnology company Crucell N.V. (Euronext, Nasdaq: CRXL ; Swiss Exchange: CRX), today announced that Hungary-based Gedeon Richter Plc. signed a commercial...

DSM and Crucell Announce Another Key Achievement for PER.C6(R) Technology; Scale Up of High-Titer Fed-Batch Process to 250 Liters

GRONINGEN and LEIDEN, Netherlands and PARSIPPANY, N.J., Sept. 29 /PRNewswire/ -- DSM Biologics and Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) announced today that the high-titer fed-batch process developed at the PERCIVIA PER.C6(R) Development Center, their joint venture in Camb...

World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

...ayers. Major market participants in the nanomedicine market include Abraxis BioScience Inc., AMAG Pharmaceuticals Inc, Arrowhead Research Corporation, crucell N.V., Flamel Technologies S.A., Elan Corporation Plc, Enzon Pharmaceuticals Inc., Life Technologies Corporation, Nanosphere Inc., Nektar Therapeutics,...

KBI Biopharma Starts Cell Line Generation Process under Vendor Network Agreement for PER.C6(R)

...hon added, "Our KBI scientific team has extensive experience producing cell lines in microbial, insect and mammalian systems and are very pleased that crucell and DSM have recognized our expertise by selecting KBI as a Partner for their Vendor Network." KBI is now proud to offer the PER.C6(R) technolog...

Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009

...ain cancer. Other Developments -- Avid Bioservices became the first U.S. pre-approved contract manufacturer for licensees of the DSM Biologics and crucell PER.C6(R) cell line, a proprietary high yield cell line with important advantages over other approaches. -- Received a Staff Determination letter fr...

DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody

...exclusive rights, along with Dutch biotech company crucell N.V., to license the high-producing PER.C6(R) huma...hat are difficult to predict and therefore DSM and crucell do not guarantee that their expectations will be realized. Furthermore, DSM and crucell have no obligation to update the statements contai...
Other Tags
(Date:10/1/2014)... Anti Aging Clinic (AntiAgingClinic.ca), the Greater Toronto ... choice, is announcing a discounted cost on Botox units, ... “We’re doing this because we want to give as ... clinic in Toronto,” says Dr. Brian Sieber, founder of ... Aging Clinic, including laser facials, genesis laser facials, ...
(Date:10/1/2014)... October 01, 2014 Nordic Naturals ... a very special cause. The campaign—“Buy One Bottle. ... Paws for Veterans, a nonprofit organization that helps ... rescuing shelter dogs that would otherwise face euthanasia. ... products will support monthly donations of Nordic Naturals ...
(Date:10/1/2014)... 2014 Today marks the final day ... Institute in Oxnard and Woodland Hills, Calif., is in ... rehabilitation training. , “Speaking to this group of specialists ... to get the help and care they deserve,” Dr. ... previous dental work, providing cosmetic dentistry, correcting bite issues, ...
(Date:10/1/2014)... 2014 UP4 Probiotics will be donating ... to The National Network to End Domestic Violence ( ... was chosen through nationwide polling that took place during ... outlets. , “We are proud to have been ... every sale of UP4 Women’s Probiotics during the month ...
(Date:10/1/2014)... This weekend Pope Francis drew world-wide attention to ... to 40,000 seniors in St. Peter's Square in the Vatican, ... "Violence against the elderly is as inhuman as that against ... people just discarded, victims of an abandonment that is tantamount ... culture that is hurting our world so much," he said. ...
Breaking Medicine News(10 mins):Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2Health News:Nordic Naturals® Inspires Support for Paws for Veterans -- ‘Buy One Bottle. Help Two Heroes.’ Initiative Kicks Off October 1 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 3Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 4Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 5Health News:UP4 Probiotics Partners with The National Network to End Domestic Violence 2Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 2Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 3
(Date:9/30/2014)... , Sept. 30, 2014  Spectra ... solutions for the biotech and power generation ... new RECONN Bioprocess Manager, an easy-to-use and ... geared towards bioprocess development laboratories. ... disparate bioreactor and analyzer systems. Accessing and ...
(Date:9/29/2014)... new study confirms that the exposure to tar tended ... of regular cigarettes. Similarly, exposure to nicotine tended ... popular type of cigarette in several countries around the ... certain toxic chemicals in the smoke of these cigarettes ... lower levels of chemicals in the smoke are not ...
(Date:9/29/2014)... CORVALLIS, Ore. Parents with children at home should ... from Oregon State University are recommending, after a new ... and asthma, asthma symptoms and chronic bronchitis. , "In ... the prevalence of asthma and wheezing is higher than ... ventilation," said Ellen Smit, an associate professor in the ...
Breaking Biology News(10 mins):Spectra Automation Introduces RECONN Bioprocess Manager 2Slim cigarette smokers not exposed to more harmful chemicals 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 3
Other Contents